Pyxis Oncology, Inc. (PYXS) Discusses Preliminary Phase 1 Data for MICVO in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Transcript

PresentationI would now like to turn the conference over to Alex Kane, Senior Vice President of Investor Relations and Capital Markets. Please go ahead.Ladies and gentlemen, thank you for standing by. Welcome to Pyxis Oncology MICVO Clinical Update Call. [Operator Instructions] Please be advised that today's conference is being recorded.Alex KaneSenior Vice President of Investor Relations & Capital Markets Hi, and good morning, everyone. My name is Alex Kane, and I'm the Senior Vice President of Investor Re ...